The Aesthetic Society requires all faculty, authors, planners, reviewers, moderators, staff and all other individuals in a position to control or influence the content of an activity to disclose all financial relationships in the past 24 months. The Aesthetic Society also requires faculty/authors to disclose when off-label/ unapproved uses of products are discussed in a CME activity or included in related materials.
All identified relevant financial relationships have been mitigated and the educational content thoroughly evaluated by The Aesthetic Society for fair, balanced, and safe, effective patient care.
Christopher Surek, DO
Cypris Medical: Consultant, Stock/Options; Galderma Laboratories: LP: Consultant, Cost Reimbursements, Honoraria, Rees; Allergan: Consultant, Cost Reimbursements, Honoraria;
Jason Roostaeian, MD
nothing to disclose
Richard Bensimon, MD
nothing to disclose
Francisco Bravo, MD
nothing to disclose
Louis Bucky, MD
PatientFi: Advisor, Investor: Stock/Options
Steven Cohen, MD
Recure: Advisor, Investor, Luminary, Stock/Options; Merz Aesthetics: Research Support; Apyx Medical: Consultant, Investigator, Research Support, Other Compensation; Mage: Advisor, Investor, Luminary, Royalties, Stock/Options; Millennium Medical Technologies: Advisor, Consultant, Stock/Options; Paracrine: Shareholder, Investigator
Dino Elyassnia, MD
nothing to disclose
Glenn Jelks, MD
nothing to disclose
Aaron Kosins, MD
ZO Skin Health: Consultant, Shareholder; Micrins - Consultant; QMP - Consultant; Royalties
Michael Lee, MD
Durasorb - Investor
Gabriele Miotto, MD
nothing to disclose
Oren Tepper, MD
Mirrorme3D: Investor, Stock/Options
Patrick Tonnard, MD
Tulip, Inc. - Royalties
Richard Warren, MD
nothing to disclose
Richard Zoumalan, MD
nothing to disclose |